Global Immuno-Oncology Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 14-Dec-2023
No. of pages: 123

Market Overview of Global Immuno-Oncology market:

According to our latest research, the global Immuno-Oncology market looks promising in the next 5 years. As of 2022, the global Immuno-Oncology market was estimated at USD 40313.8 million, and it's anticipated to reach USD 115591.0 million in 2028, with a CAGR of 19.19% during the forecast years.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Immuno-Oncology market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Immuno-Oncology Market Report:

Market Size Estimates: Immuno-Oncology market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Immuno-Oncology market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Immuno-Oncology market

Segment Market Analysis: Immuno-Oncology market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Immuno-Oncology market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Immuno-Oncology Market: Revenue and sales volume of major countries in each region

Immuno-Oncology Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Immuno-Oncology market in major regions.

Immuno-Oncology Industry Value Chain: Immuno-Oncology market raw materials & suppliers, manufacturing process, distributors, downstream customers

Immuno-Oncology Industry News, Policies & Regulations

Key players in the global Immuno-Oncology market are covered in Chapter 12:

Hoffmann-La Roche AG

Galena Biopharma

Bavarian Nordic

Johnson & Johnson

Aduro BioTech

Novartis International AG

Merck & Co.

Celldex Therapeutics

ImmunoCellular Therapeutics

Eli Lilly and Company

Bristol-Myers Squibb

Incyte

AstraZeneca, Plc

Gilead Sciences Inc.

Prometheus Therapeutics & Diagnostics

Celgene Corporation

Amgen, Inc

EMD Serono

Pfizer Inc.

Sanofi S.A.

AbbVie

In Chapter 2 and Chapter 15.1, based on types, the Immuno-Oncology market from 2018 to 2028 is primarily split into:

Immune Checkpoint Inhibitors

Immune System Modulators

Cancer Vaccines

Oncolytic Virus

In Chapter 3 and Chapter 15.2, based on applications, the Immuno-Oncology market from 2018 to 2028 covers:

Hospitals

Clinics

Ambulatory Surgical Centers

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Immuno-Oncology market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Immuno-Oncology Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Immuno-Oncology Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Immuno-Oncology Market Size (2018-2028)
1.3.1 Global Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Immuno-Oncology Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Immuno-Oncology Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Immuno-Oncology Historic Revenue ($) by Type (2018-2023)
2.2 Global Immuno-Oncology Historic Sales Volume by Type (2018-2023)
2.3 Immune Checkpoint Inhibitors Sales and Price (2018-2023)
2.4 Immune System Modulators Sales and Price (2018-2023)
2.5 Cancer Vaccines Sales and Price (2018-2023)
2.6 Oncolytic Virus Sales and Price (2018-2023)

3 Global Immuno-Oncology Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Immuno-Oncology Historic Revenue ($) by Application (2018-2023)
3.2 Global Immuno-Oncology Historic Sales Volume by Application (2018-2023)
3.3 Hospitals Sales, Revenue and Growth Rate (2018-2023)
3.4 Clinics Sales, Revenue and Growth Rate (2018-2023)
3.5 Ambulatory Surgical Centers Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Immuno-Oncology Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Immuno-Oncology Industry News
4.7.2 Immuno-Oncology Industry Policies

5 Global Immuno-Oncology Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Immuno-Oncology Sales Volume by Region (2018-2023)
5.2 Global Immuno-Oncology Market Revenue ($) by Region (2018-2023)

6 Global Immuno-Oncology Import Volume and Export Volume by Major Regions
6.1 Global Immuno-Oncology Import Volume by Region (2018-2023)
6.2 Global Immuno-Oncology Export Volume by Region (2018-2023)

7 North America Immuno-Oncology Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
7.2 North America Immuno-Oncology Market Trends Analysis Under Global Inflation
7.3 North America Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Immuno-Oncology Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Immuno-Oncology Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Immuno-Oncology Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)

9 Europe Immuno-Oncology Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
9.2 Europe Immuno-Oncology Market Trends Analysis Under Global Inflation
9.3 Europe Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)

10 Latin America Immuno-Oncology Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Immuno-Oncology Market Trends Analysis Under Global Inflation
10.3 Latin America Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Immuno-Oncology Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Immuno-Oncology Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Immuno-Oncology Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Immuno-Oncology Revenue ($) and Market Share of Key Players
12.1.2 Global Immuno-Oncology Sales Volume and Market Share of Key Players
12.1.3 Global Immuno-Oncology Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 Hoffmann-La Roche AG Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Galena Biopharma Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Galena Biopharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Bavarian Nordic Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Bavarian Nordic Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 Johnson & Johnson Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 Johnson & Johnson Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Aduro BioTech Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Aduro BioTech Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Novartis International AG Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Novartis International AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Merck & Co. Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Celldex Therapeutics Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Celldex Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 ImmunoCellular Therapeutics Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 ImmunoCellular Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 Eli Lilly and Company Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 Eli Lilly and Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 Bristol-Myers Squibb Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 Bristol-Myers Squibb Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Incyte Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Incyte Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 AstraZeneca, Plc Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 AstraZeneca, Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Gilead Sciences Inc. Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Gilead Sciences Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 Prometheus Therapeutics & Diagnostics Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 Prometheus Therapeutics & Diagnostics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 Celgene Corporation Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 Celgene Corporation Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 Amgen, Inc Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 Amgen, Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 EMD Serono Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 EMD Serono Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.20 Pfizer Inc. Market Performance and Business Analysis
12.20.1 Company Profiles
12.20.2 Product Profiles and Application
12.20.3 Pfizer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.21 Sanofi S.A. Market Performance and Business Analysis
12.21.1 Company Profiles
12.21.2 Product Profiles and Application
12.21.3 Sanofi S.A. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.22 AbbVie Market Performance and Business Analysis
12.22.1 Company Profiles
12.22.2 Product Profiles and Application
12.22.3 AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Immuno-Oncology Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Immuno-Oncology
13.3.3 Raw Material Cost of Immuno-Oncology
13.3.4 Labor Cost of Immuno-Oncology
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Immuno-Oncology Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Immuno-Oncology Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Immuno-Oncology Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Immuno-Oncology Sales Volume Forecast by Type (2023-2028)
15.2 Global Immuno-Oncology Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Immuno-Oncology Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Immuno-Oncology Sales Volume Forecast by Application (2023-2028)
15.3 Global Immuno-Oncology Sales Volume Forecast by Region (2023-2028)
15.4 Global Immuno-Oncology Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Immuno-Oncology Picture
Table Immuno-Oncology Definition
Table Description and Definitions
Figure Immune Checkpoint Inhibitors Features
Figure Immune System Modulators Features
Figure Cancer Vaccines Features
Figure Oncolytic Virus Features
Table Description and Definitions
Figure Hospitals
Figure Clinics
Figure Ambulatory Surgical Centers
Figure North America Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Europe Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Global Immuno-Oncology Revenue ($) and Growth Rate (2018-2028)
Figure Global Immuno-Oncology Sales Volume and Growth Rate (2018-2028)
Table Global Immuno-Oncology Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Immuno-Oncology Historic Revenue ($) Share by Type (2018-2023)
Table Global Immuno-Oncology Historic Sales Volume by Type (2018-2023)
Table Global Immuno-Oncology Historic Sales Volume Share by Type (2018-2023)
Figure Global Immune Checkpoint Inhibitors Sales and Growth Rate (2018-2023)
Figure Global Immune Checkpoint Inhibitors Price (2018-2023)
Figure Global Immune System Modulators Sales and Growth Rate (2018-2023)
Figure Global Immune System Modulators Price (2018-2023)
Figure Global Cancer Vaccines Sales and Growth Rate (2018-2023)
Figure Global Cancer Vaccines Price (2018-2023)
Figure Global Oncolytic Virus Sales and Growth Rate (2018-2023)
Figure Global Oncolytic Virus Price (2018-2023)
Table Global Immuno-Oncology Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Immuno-Oncology Historic Revenue ($) Share by Application (2018-2023)
Table Global Immuno-Oncology Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Immuno-Oncology Historic Sales Volume Share by Application (2018-2023)
Figure Global Hospitals Sales and Growth Rate (2018-2023)
Figure Global Hospitals Revenue and Growth Rate (2018-2023)
Figure Global Clinics Sales and Growth Rate (2018-2023)
Figure Global Clinics Revenue and Growth Rate (2018-2023)
Figure Global Ambulatory Surgical Centers Sales and Growth Rate (2018-2023)
Figure Global Ambulatory Surgical Centers Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Immuno-Oncology Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Immuno-Oncology Sales Volume by Region (2018-2023)
Table Global Immuno-Oncology Sales Volume Share by Region (2018-2023)
Table Global Immuno-Oncology Market Revenue ($) by Region (2018-2023)
Table Global Immuno-Oncology Market Revenue ($) Share by Region (2018-2023)
Table Global Immuno-Oncology Import Volume by Region (2018-2023)
Table Global Immuno-Oncology Export Volume by Region (2018-2023)
Figure North America Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure North America Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
Table North America Immuno-Oncology Market Trends Analysis Under Global Inflation
Table North America Immuno-Oncology Revenue ($) by Country (2018-2023)
Table North America Immuno-Oncology Sales Volume by Country (2018-2023)
Figure United States Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Canada Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Immuno-Oncology Market Trends Analysis Under Global Inflation
Table Asia Pacific Immuno-Oncology Revenue ($) by Country (2018-2023)
Table Asia Pacific Immuno-Oncology Sales Volume by Country (2018-2023)
Figure China Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Japan Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure India Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Immuno-Oncology Revenue ($) by Country (2018-2023)
Figure Australia Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Europe Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Europe Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
Table Europe Immuno-Oncology Market Trends Analysis Under Global Inflation
Table Europe Immuno-Oncology Revenue ($) by Country (2018-2023)
Table Europe Immuno-Oncology Sales Volume by Country (2018-2023)
Figure Germany Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure France Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Italy Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Spain Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Russia Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Poland Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
Table Latin America Immuno-Oncology Market Trends Analysis Under Global Inflation
Table Latin America Immuno-Oncology Revenue ($) by Country (2018-2023)
Table Latin America Immuno-Oncology Sales Volume by Country (2018-2023)
Figure Mexico Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Immuno-Oncology Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Immuno-Oncology Market Trends Analysis Under Global Inflation
Table Middle East and Africa Immuno-Oncology Revenue ($) by Country (2018-2023)
Table Middle East and Africa Immuno-Oncology Sales Volume by Country (2018-2023)
Figure GCC Countries Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Figure Africa Immuno-Oncology Revenue ($) and Growth Rate (2018-2023)
Table Global Immuno-Oncology Revenue ($) of Key Players (2018-2023)
Table Global Immuno-Oncology Revenue ($) Share of Key Players (2018-2023)
Table Global Immuno-Oncology Sales Volume of Key Players (2018-2023)
Table Global Immuno-Oncology Sales Volume Share of Key Players (2018-2023)
Table Global Immuno-Oncology Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table Hoffmann-La Roche AG Company Profiles
Table Product Profiles and Application
Table Hoffmann-La Roche AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Hoffmann-La Roche AG Production and Growth Rate
Figure Hoffmann-La Roche AG Value ($) Market Share 2018-2023
Table Galena Biopharma Company Profiles
Table Product Profiles and Application
Table Galena Biopharma Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Galena Biopharma Production and Growth Rate
Figure Galena Biopharma Value ($) Market Share 2018-2023
Table Bavarian Nordic Company Profiles
Table Product Profiles and Application
Table Bavarian Nordic Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bavarian Nordic Production and Growth Rate
Figure Bavarian Nordic Value ($) Market Share 2018-2023
Table Johnson & Johnson Company Profiles
Table Product Profiles and Application
Table Johnson & Johnson Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2018-2023
Table Aduro BioTech Company Profiles
Table Product Profiles and Application
Table Aduro BioTech Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Aduro BioTech Production and Growth Rate
Figure Aduro BioTech Value ($) Market Share 2018-2023
Table Novartis International AG Company Profiles
Table Product Profiles and Application
Table Novartis International AG Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novartis International AG Production and Growth Rate
Figure Novartis International AG Value ($) Market Share 2018-2023
Table Merck & Co. Company Profiles
Table Product Profiles and Application
Table Merck & Co. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Value ($) Market Share 2018-2023
Table Celldex Therapeutics Company Profiles
Table Product Profiles and Application
Table Celldex Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celldex Therapeutics Production and Growth Rate
Figure Celldex Therapeutics Value ($) Market Share 2018-2023
Table ImmunoCellular Therapeutics Company Profiles
Table Product Profiles and Application
Table ImmunoCellular Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure ImmunoCellular Therapeutics Production and Growth Rate
Figure ImmunoCellular Therapeutics Value ($) Market Share 2018-2023
Table Eli Lilly and Company Company Profiles
Table Product Profiles and Application
Table Eli Lilly and Company Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2018-2023
Table Bristol-Myers Squibb Company Profiles
Table Product Profiles and Application
Table Bristol-Myers Squibb Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2018-2023
Table Incyte Company Profiles
Table Product Profiles and Application
Table Incyte Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Incyte Production and Growth Rate
Figure Incyte Value ($) Market Share 2018-2023
Table AstraZeneca, Plc Company Profiles
Table Product Profiles and Application
Table AstraZeneca, Plc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AstraZeneca, Plc Production and Growth Rate
Figure AstraZeneca, Plc Value ($) Market Share 2018-2023
Table Gilead Sciences Inc. Company Profiles
Table Product Profiles and Application
Table Gilead Sciences Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Gilead Sciences Inc. Production and Growth Rate
Figure Gilead Sciences Inc. Value ($) Market Share 2018-2023
Table Prometheus Therapeutics & Diagnostics Company Profiles
Table Product Profiles and Application
Table Prometheus Therapeutics & Diagnostics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Prometheus Therapeutics & Diagnostics Production and Growth Rate
Figure Prometheus Therapeutics & Diagnostics Value ($) Market Share 2018-2023
Table Celgene Corporation Company Profiles
Table Product Profiles and Application
Table Celgene Corporation Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celgene Corporation Production and Growth Rate
Figure Celgene Corporation Value ($) Market Share 2018-2023
Table Amgen, Inc Company Profiles
Table Product Profiles and Application
Table Amgen, Inc Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Amgen, Inc Production and Growth Rate
Figure Amgen, Inc Value ($) Market Share 2018-2023
Table EMD Serono Company Profiles
Table Product Profiles and Application
Table EMD Serono Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure EMD Serono Production and Growth Rate
Figure EMD Serono Value ($) Market Share 2018-2023
Table Pfizer Inc. Company Profiles
Table Product Profiles and Application
Table Pfizer Inc. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2018-2023
Table Sanofi S.A. Company Profiles
Table Product Profiles and Application
Table Sanofi S.A. Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sanofi S.A. Production and Growth Rate
Figure Sanofi S.A. Value ($) Market Share 2018-2023
Table AbbVie Company Profiles
Table Product Profiles and Application
Table AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Immuno-Oncology
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Immuno-Oncology with Contact Information
Figure Production Process of Immuno-Oncology
Figure Manufacturing Cost Structure of Immuno-Oncology
Table Major Distributors of Immuno-Oncology with Contact Information
Table Major Downstream Buyers of Immuno-Oncology with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Immuno-Oncology Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Immuno-Oncology Revenue ($) Share Forecast by Type (2023-2028)
Table Global Immuno-Oncology Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Immuno-Oncology Sales Volume Share Forecast by Type (2023-2028)
Table Global Immuno-Oncology Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Immuno-Oncology Revenue ($) Share Forecast by Application (2023-2028)
Table Global Immuno-Oncology Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Immuno-Oncology Sales Volume Share Forecast by Application (2023-2028)
Table Global Immuno-Oncology Sales Volume Forecast by Region (2023-2028)
Table Global Immuno-Oncology Sales Volume Share Forecast by Region (2023-2028)
Table Global Immuno-Oncology Revenue ($) Forecast by Region (2023-2028)
Table Global Immuno-Oncology Revenue ($) Share Forecast by Region (2023-2028)
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs